Literature DB >> 14625236

Proton MR spectroscopy of polymicrogyria and heterotopia.

Elysa Widjaja1, Paul D Griffiths, Iain D Wilkinson.   

Abstract

BACKGROUND AND
PURPOSE: Proton MR spectroscopy of the brain allows noninvasive in vivo assessment of metabolites, which may be useful in understanding the biology of malformations of cortical development. The aim of this study was to determine the MR spectroscopic characteristics of polymicrogyria and heterotopia compared with those of normal frontal lobe white matter.
METHODS: We recruited 22 patients with radiographic findings characteristic of polymicrogyria, nine patients with radiographic findings characteristic of heterotopia, and 10 control subjects into the study. The MR imaging technique consisted of high-spatial-resolution axial dual-echo and gradient-echo 3D volume imaging. A single-voxel point-resolved technique (1600/135 [TR/TE]) was used to acquire spectra from the region of neocortical malformation and from frontal lobe white matter in control subjects. The differences in N-acetyl moieties (NA)/creatine (Cr), NA/choline (Cho), and Cho/Cr ratios among patients with heterotopia, those with polymicrogyria, and control subjects were compared by using the Kruskal-Wallis test followed by the Mann-Whitney U (Wilcoxon) test.
RESULTS: No statistically significant differences were noted in the NA/Cr, NA/Cho, and Cho/Cr ratios between the polymicrogyria group and controls, the heterotopia group and controls, or the polymicrogyria and heterotopia groups.
CONCLUSION: Both heterotopia and polymicrogyria are malformations of cortical development that occur at a relatively late stage of brain development. The neurons and glia in these lesions are mature, and the metabolites appear to be similar to those of normal adult frontal white matter.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625236      PMCID: PMC8148926     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  25 in total

1.  Proton spectroscopic imaging at 4.1 tesla in patients with malformations of cortical development and epilepsy.

Authors:  R Kuzniecky; H Hetherington; J Pan; J Hugg; C Palmer; F Gilliam; E Faught; R Morawetz
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

2.  Spatially localized 1H NMR spectra of metabolites in the human brain.

Authors:  C C Hanstock; D L Rothman; J W Prichard; T Jue; R G Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  Proton MR spectroscopy of cortical tubers in adults with tuberous sclerosis complex.

Authors:  W Mukonoweshuro; I D Wilkinson; P D Griffiths
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

4.  Classification system for malformations of cortical development: update 2001.

Authors:  A J Barkovich; R I Kuzniecky; G D Jackson; R Guerrini; W B Dobyns
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

5.  Proton magnetic resonance spectroscopy in disturbances of cortical development.

Authors:  T Kaminaga; M Kobayashi; T Abe
Journal:  Neuroradiology       Date:  2001-07       Impact factor: 2.804

6.  Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain.

Authors:  M S van der Knaap; J van der Grond; P C van Rijen; J A Faber; J Valk; K Willemse
Journal:  Radiology       Date:  1990-08       Impact factor: 11.105

7.  Neuronal metabolic dysfunction in patients with cortical developmental malformations: a proton magnetic resonance spectroscopic imaging study.

Authors:  L M Li; F Cendes; A C Bastos; F Andermann; F Dubeau; D L Arnold
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910

8.  Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging.

Authors:  G Tedeschi; A Bertolino; A Righini; G Campbell; R Raman; J H Duyn; C T Moonen; J R Alger; G Di Chiro
Journal:  Neurology       Date:  1995-07       Impact factor: 9.910

9.  Developmental brain changes investigated with proton magnetic resonance spectroscopy.

Authors:  T Hashimoto; M Tayama; M Miyazaki; E Fujii; M Harada; H Miyoshi; M Tanouchi; Y Kuroda
Journal:  Dev Med Child Neurol       Date:  1995-05       Impact factor: 5.449

Review 10.  Proton MR spectroscopy in ischemic stroke and other vascular disorders.

Authors:  P E Ricci
Journal:  Neuroimaging Clin N Am       Date:  1998-11       Impact factor: 2.264

View more
  5 in total

1.  Midline "brain in brain": an unusual variant of holoprosencephaly with anterior prosomeric cortical dysplasia.

Authors:  E Widjaja; L Massimi; S Blaser; C Di Rocco; C Raybaud
Journal:  Childs Nerv Syst       Date:  2006-11-11       Impact factor: 1.475

2.  The use of MR imaging and spectroscopy of the brain in children investigated for developmental delay: what is the most appropriate imaging strategy?

Authors:  Paul D Griffiths; Ruth Batty; Daniel Warren; Anthony Hart; Mark Sharrard; Santosh R Mordekar; Ashok Raghavan; Daniel J A Connolly
Journal:  Eur Radiol       Date:  2011-05-10       Impact factor: 5.315

3.  Multivoxel proton MR spectroscopy in malformations of cortical development.

Authors:  C C Leite; L T Lucato; J R Sato; K D Valente; M C G Otaduy
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825

4.  Subcortical heterotopia appearing as huge midline mass in the newborn brain.

Authors:  Shinobu Fukumura; Toshihide Watanabe; Sachiko Kimura; Satoko Ochi; Kazuhisa Yoshifuji; Hiroyuki Tsutsumi
Journal:  Childs Nerv Syst       Date:  2015-08-01       Impact factor: 1.475

5.  CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy.

Authors:  L Jardim; L Vedolin; I V D Schwartz; M G Burin; C Cecchin; L Kalakun; U Matte; F Aesse; C Pitta-Pinheiro; J Marconato; R Giugliani
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.